| Net Cash Provided by (Used in) Operating Activities |
$158,143 |
USD |
51% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$356,000 |
USD |
-59% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$225,000 |
USD |
58% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,804 |
USD |
1037% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$460,667 |
USD |
125% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$460,667 |
USD |
125% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |